Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

6.18
BATS BZX Real-Time Price
As of 12:47pm ET
 +0.06 / +0.98%
Today’s Change
1.51
Today|||52-Week Range
8.04
+202.94%
Year-to-Date

Today’s Trading

Previous close6.12
Today’s open6.24
Day’s range6.13 - 6.52
Volume162,027
Average volume (3 months)2,571,518
Market cap$546.8M
Dividend yield--
Data as of 12:47pm ET, 07/26/2017

Growth & Valuation

Earnings growth (last year)-154.93%
Earnings growth (this year)+28.35%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-49.72%
P/E ratioNM
Price/Sales4.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AUPHAurinia Pharmaceutic...+0.05+0.78%
ANABAnaptysBio Inc-3.90-13.98%
MCRBSeres Therapeutics I...+0.55+3.92%
ADAPAdaptimmune Therapeu...-0.05-0.90%
Data as of 12:43pm ET, 07/26/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$43.0M
Annual profit (last year)-$157.8M
Net profit margin-366.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts